Ekso Bionics Holdings EBIT Margin 2013-2024 | EKSO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Ekso Bionics Holdings ebit margin from 2013 to 2024. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Ekso Bionics Holdings ebit margin from 2013 to 2024. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$206.8B
Intuitive Surgical (ISRG)	$191.3B
Alcon (ALC)	$42.9B
Edwards Lifesciences (EW)	$38.8B
IQVIA Holdings (IQV)	$38.8B
IDEXX Laboratories (IDXX)	$34.9B
DexCom (DXCM)	$29B
Waters (WAT)	$22.9B
STERIS (STE)	$22B
SONOVA HOLDING (SONVY)	$21.6B
Hologic (HOLX)	$18.5B
Sysmex ADR (SSMXY)	$12.6B
Fresenius Medical Care AG KGaA (FMS)	$12.4B
Globus Medical (GMED)	$11.3B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.6B
TransMedics (TMDX)	$3.1B
Inari Medical (NARI)	$3B
Veracyte (VCYT)	$3B
LivaNova (LIVN)	$2.9B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B